Temozolomide chemotherapy in patients with recurrent malignant gliomas. - Wikidata - wikimedia - TriplyDB

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

http://www.wikidata.org/entity/Q37313220

about

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM The efficacy of temozolomide for recurrent glioblastoma multiforme.Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates.Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma.The efficacy and safety of various dose-dense regimens of temozolomide for recurrent high-grade glioma: a systematic review with meta-analysis.Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials.Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation.

P2860

Q33382214-F2EB76A8-9EA5-4C59-B6E7-44F4FDA73DDD Q33712977-9AB7BD42-201A-4276-B36A-EF548F4C4BEB Q34297519-E84C4A8B-4182-490C-A6A7-81FF288FE724 Q36444444-66E6EEF2-4A83-47C6-9D1A-4EC0D8D5C071 Q37438154-5612B443-7B0B-4601-94CA-E90802276CBC Q37578075-259591B6-04FC-481C-A2D3-F4A2A8EF76FD Q38579564-03F9A89A-FE75-40ED-9EC1-3E033CB7CF0F Q38720644-3C989CFC-BC57-4BE3-9803-0FD4B577B746 Q55042008-1F3B211E-0BFB-4D3B-A8EF-8F3A2C390DC2

P2860

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

http://www.wikidata.org/entity/Q37313220

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

@en

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

@nl

type

label

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

@en

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

@nl

prefLabel

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

@en

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

@nl

P1433

Q37313220-2C6A10DE-0EDE-45C2-BBB9-7FE13E5D554A

P1476

Q37313220-D222F98D-EB3F-4C3F-919B-715AF2CF43E5

P2093

Q37313220-3C85957A-2AA0-4103-9F16-0926156AB1FA

Q37313220-55B36344-9034-43AD-B5A4-9C52E4D127EC

Q37313220-8BD80857-40DF-4AFD-A02E-4DECDCC2C478

Q37313220-8DAFF500-8BA9-4D1C-9D7C-C4C81636E339

Q37313220-9663AE73-C526-4622-BA4D-C3505F4924EA

Q37313220-BE9E9465-4F7A-4EBA-AABD-1BF244DEBE84

Q37313220-C25B55B9-E5DD-4DFC-B171-EC513F1DD11F

Q37313220-FBA18C2D-4E48-4942-BD58-6506DFA1E129

Q37313220-FC355F24-1DA9-4000-8B3F-791296AF307C

P2860

Q37313220-0AC3DBC7-6F86-42EE-B6DF-6D40B7C2CDA3

Q37313220-26495905-6499-423C-A6F2-07A94EE48749

Q37313220-307590DD-AE8C-4AE3-892F-B1EBC800E67A

Q37313220-56DCDC0D-4A71-4BA2-8DF1-C9D9A6E67C47

Q37313220-59D8CBA8-51ED-4444-97A7-D8FBEA3087EE

Q37313220-5F486030-F50E-4773-9FC4-7C87D09872D9

Q37313220-8F89E1FF-8406-47E2-A989-4F45A7F9973E

Q37313220-9A8768FC-409D-4FFA-AB09-B56FF0632547

Q37313220-9AB5C3BC-38BB-4E7F-9F39-525A2CB98235

Q37313220-A77DE34C-3994-40A2-B2DA-A6CEDC8C92BB

P304

Q37313220-E66F4537-D606-4CE7-B6EB-63CB519C5F5B

P31

Q37313220-F324141A-D9EB-4787-AE45-FC4812B8F243

P356

Q37313220-2351DE65-4E4D-44D2-9502-DDD24A0AD7E4

P433

Q37313220-83F71356-E733-45A0-9734-A5B1771FC8CD

P478

Q37313220-6016F92F-DC30-4B35-9E1D-4F30477479BF

P577

Q37313220-067404F0-D5E9-4B22-BC93-DB9F09DE0266

P5875

Q37313220-97487AC8-B684-4491-BF9A-ACFD86D15C2C

P698

Q37313220-2389048A-713C-43E4-B3B4-05D87F401CC8

P921

Q37313220-287B408A-5A31-404E-90D4-49A62DE2C879

P932

Q37313220-4A6D634D-7B1B-4A90-99A3-676F3356A4AB

P356

JKMS.2006.21.4.739

P1433

Journal of Korean Medical Science

P1476

Temozolomide chemotherapy in patients with recurrent malignant gliomas.

@en

P2093

Chun-Kun Park

http://www.w3.org/2001/XMLSchema#string

Joon-Ki Kang

http://www.w3.org/2001/XMLSchema#string

Kwan-Sung Lee

http://www.w3.org/2001/XMLSchema#string

Moon-Chan Kim

http://www.w3.org/2001/XMLSchema#string

Moon-Kyu Kim

http://www.w3.org/2001/XMLSchema#string

Seung-Ho Yang

http://www.w3.org/2001/XMLSchema#string

Sin-Soo Jeun

http://www.w3.org/2001/XMLSchema#string

Tae-Kyu Lee

http://www.w3.org/2001/XMLSchema#string

Yong-Kil Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Reporting results of cancer treatment

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

The use of temozolomide in recurrent malignant gliomas.

A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma

Current and future developments in the use of temozolomide for the treatment of brain tumours.

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

P304

739-744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2006.21.4.739

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6894894

http://www.w3.org/2001/XMLSchema#string

P698

16891823

http://www.w3.org/2001/XMLSchema#string

P921

P932

2729901

http://www.w3.org/2001/XMLSchema#string